Herbert Smith Freehills has advised Nuchev Limited on its successful A$117 million IPO on the ASX.

Nuchev is an Australian-based, globally-orientated food business with a dedicated focus on developing, marketing, and selling a range of premium Australian-made goat nutritional products. Nuchev sells premium goat infant formula, offering differentiated health benefits relative to other infant formula products, and goat full cream milk powder under the Oli6® brand in Australia, China, and Hong Kong.

The Herbert Smith Freehills team was led by partner Tim McEwen who was supported by senior associates Sam Kings and Andrew Earle, and solicitors Jennifer Wong and James Paolucci. The firm has also acted for Nuchev on its pre-IPO capital and debt raisings, as well as other transactions, since its establishment in 2013.  

Tim McEwen said, “We wish Nuchev all the best as it commences its life as a listed company. The fact that Nuchev was built from scratch over the last six years and is now listed on ASX is a great reflection on its management team and shareholders. We have appreciated the opportunity to work with Nuchev throughout its journey and look forward to continuing to do so”.

Wilsons acted as lead manager and Reunion Capital Partners as independent financial adviser on the IPO.

This deal is another example of Herbert Smith Freehills’ market-leading work in IPOs. Other recent examples include Carbon Revolution and Prospa Group.